Tolerance of normal human brain to boron neutron capture therapy

Applied Radiation and Isotopes

Volumn 61, Issue 5, 2004, Pages 1083-1087

  Coderre, J A ^a   Hopewell, J W ^b   Turcotte, J C ^a   Riley, K J ^c   Binns, P J ^c   Kiger III, W S ^d   Harling, O K ^a  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

BNCT; Brain; Somnolence syndrome; Tolerance

Indexed keywords

BRAIN; MEDICAL IMAGING; NEUTRON BEAMS; RADIOTHERAPY;

BORON NEUTRON CAPTURE THERAPY (BNCT); PROBIT ANALYSIS;

DOSIMETRY;

4 BORONOPHENYLALANINE B 10;

BRAIN TUMOR; CANCER SURGERY; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; GLIOBLASTOMA; HUMAN; MELANOMA; NEUTRON CAPTURE THERAPY; PRIORITY JOURNAL; RADIATION DOSE; SOMNOLENCE;

BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; BRAIN; BRAIN NEOPLASMS; DISORDERS OF EXCESSIVE SOMNOLENCE; GLIOBLASTOMA; HUMANS; MELANOMA; PHENYLALANINE; RADIATION TOLERANCE;

EID: 4143142122     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2004.05.009     Document Type: Conference Paper

References (16)

1. Busse P.M., Harling O.K., Palmer M.R., Kiger W.S. III, Kaplan J., Kaplan I., Chuang C.F., Goorley J.T., Riley K.J., Newton T.H., Santa Cruz G.A., Lu X.Q., Zamenhof R.G. A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease. J. Neurooncol. 62:2003;111-121
2. Chanana A.D., Capala J., Chadha M., Coderre J.A., Diaz A.Z., Elowitz E.H., Iwai J., Joel D.D., Liu H.B., Ma R., Pendzick N., Peress N.S., Shady M.S., Slatkin D.N., Tyson G.W., Wielopolski L. Boron neutron capture therapy for glioblastoma multiforme. Interim results from the phase I/II dose-escalation studies Neurosurgery. 44:1999;1182-1193
3. Coderre J.A., Morris G.M. The radiation biology of boron neutron capture therapy. Radiat. Res. 151:1999;1-18
4. Coderre J.A., Turcotte J.C., Riley K.J., Binns P.J., Harling O.K., Kiger W.S. III Boron neutron capture therapy. cellular targeting of high linear energy transfer radiation Technol. Cancer Res. Treatment. 2:2003;355-375
5. Diaz A.Z. Assessment of the results from the phase I/II boron neutron capture therapy trials at the Brookhaven National Laboratory from a clinician's point of view. J. Neurooncol. 62:2003;101-109
6. Emami B., Lyman J., Brown A., Coia L., Goitein M., Munzenrider J.E., Shank B., Solin L.J., Wesson M. Tolerance of normal tissue to therapeutic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 21:1991;109-122
7. Faithfull S., Brada M. Somnolence syndrome in adults following cranial irradiation for primary brain tumors. Clin. Oncol. 10:1998;250-254
8. Flickinger J.C., Kondziolka D., Lunsford L.D., Kassam A., Phuong L.K., Liscak R., Pollock B. Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Arteriovenous malformation radiosurgery study group. Int. J. Radiat. Oncol. Biol. Phys. 46:2000;1143-1148
9. 10B in blood after boronophenylalanine-fructose administration in humans. Radiat. Res. 155:2001;611-618
10. Palmer M.R., Goorley J.T., Kiger W.S. III, Busse P.M., Riley K.J., Harling O.K., Zamenhof R.G. Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy. Int. J. Radiat. Oncol. Biol. Phys. 53:2002;1361-1379
11. Riley K.J., Binns P.J., Greenberg D.D., Harling O.K. A physical dosimetry intercomparison for BNCT. Med. Phys. 29:2002;898-904
12. Ryan J. Radiation somnolence syndrome. J. Pediatr. Oncol. Nurs. 17:2000;50-53
13. Thames, H.D., Hendry, J.H., 1987. Radiobiological guide for radiotherapists. Fractionation in Radiotherapy. Taylor & Francis, Philadelphia, pp. 229-230.
14. van der Kogel A.J. Central nervous system radiation injury in small animal models. Gutin P.H., Leibel S.A., Sheline G.E. Radiation Injury to the Nervous System. 1991;91-111 Raven Press, New York
15. Wenz F., Steinvorth S., Lohr F., Fruehauf S., Wildermuth S., van Kampen M., Wannenmacher M. Prospective evaluation of delayed central nervous system (CNS) toxicity of hyperfractionated total body irradiation (TBI). Int. J. Radiat. Oncol. Biol. Phys. 48:2000;1497-1501
16. Wheldon T.E., Barrett A. Radiobiological modelling of the treatment of leukaemia by total body irradiation. Radiother. Oncol. 58:2001;227-233